Zhuhai Sailong Pharmaceutical Co Ltd (002898) — Tangible Net Worth Ratio
Zhuhai Sailong Pharmaceutical Co Ltd (002898) has a Tangible Net Worth Ratio of 72.3% as of March 2026. This metric is calculated by deducting intangible assets (CN¥104.55 Million) from net assets (CN¥377.94 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore 002898 net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Zhuhai Sailong Pharmaceutical Co Ltd Tangible Net Worth Ratio (2013–2025)
This chart shows how Zhuhai Sailong Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 13 annual periods from 2013 to 2025. As of March 2026, the ratio stands at 72.3%, reflecting net assets of CN¥377.94 Million with intangible assets of CN¥104.55 Million CNY. For live market cap and overall valuation, see Zhuhai Sailong Pharmaceutical Co Ltd (002898) total market value.
Annual Tangible Net Worth Ratio for Zhuhai Sailong Pharmaceutical Co Ltd (2013–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Zhuhai Sailong Pharmaceutical Co Ltd from 2013 to 2025, covering 13 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore how much does Zhuhai Sailong Pharmaceutical Co Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 72.6% | CN¥384.15 Million | CN¥105.07 Million | CN¥832.10 Million | ▼ -2.6 pp |
| 2024 | 75.2% | CN¥499.28 Million | CN¥123.81 Million | CN¥808.22 Million | ▼ -3.8 pp |
| 2023 | 79.0% | CN¥535.88 Million | CN¥112.73 Million | CN¥813.84 Million | ▼ -1.2 pp |
| 2022 | 80.2% | CN¥526.35 Million | CN¥104.46 Million | CN¥847.99 Million | ▼ -1.5 pp |
| 2021 | 81.6% | CN¥563.66 Million | CN¥103.68 Million | CN¥882.78 Million | ▼ -1.7 pp |
| 2020 | 83.3% | CN¥587.00 Million | CN¥98.15 Million | CN¥813.96 Million | ▼ -2.3 pp |
| 2019 | 85.6% | CN¥659.02 Million | CN¥94.93 Million | CN¥835.98 Million | ▼ -5.3 pp |
| 2018 | 90.9% | CN¥663.54 Million | CN¥60.52 Million | CN¥755.84 Million | ▼ -0.8 pp |
| 2017 | 91.7% | CN¥618.64 Million | CN¥51.43 Million | CN¥715.13 Million | ▲ +10.3 pp |
| 2016 | 81.3% | CN¥254.45 Million | CN¥47.48 Million | CN¥305.66 Million | ▲ +4.1 pp |
| 2015 | 77.2% | CN¥213.20 Million | CN¥48.51 Million | CN¥264.73 Million | ▲ +12.5 pp |
| 2014 | 64.7% | CN¥140.55 Million | CN¥49.57 Million | CN¥189.48 Million | ▼ -31.8 pp |
| 2013 | 96.5% | CN¥111.97 Million | CN¥3.86 Million | CN¥186.41 Million | — |